Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).

被引：1
|
作者：
Chau, Nicole Grace
Li, Yvonne Y.
Hung, Yin P.
Hammerman, Peter S.
Rodig, Scott J.
Schoenfeld, Jonathan Daniel
Margalit, Danielle Nina
Lorch, Jochen H.
Rabinowits, Guilherme
Tishler, Roy B.
Haddad, Robert I.
Jo, Vickie Y.
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Div Hematopathol, Boston, MA 02115 USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Radiat Oncol, Boston, MA 02115 USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6052
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Expression of immune response biomarkers in head and neck squamous cell carcinoma (HNSCC) in irradiated area
    Pflumio, C.
    Thomas, J.
    Salleron, J.
    Faivre, J-C.
    Borel, C.
    Dolivet, G.
    Sastre-Garau, X.
    Geoffrois, L.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Relationship between PD-L1 expression and survival in head and neck squamous cell carcinoma (HNSCC) patients (pts)
    Stokes, M.
    Wang, R.
    Wildsmith, S.
    Secrier, M.
    Angell, H. K.
    Barker, C.
    Walker, J.
    Scorer, P.
    Rebelatto, M. C.
    Shire, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Weller, Patrick
    Nel, Ivonne
    Hassenkamp, Philipp
    Gauler, Thomas
    Schlueter, Anke
    Lang, Stephan
    Dountsop, Paulette
    Hoffmann, Andreas-Claudius
    Lehnerdt, Goetz
    PLOS ONE, 2014, 9 (12):
  • [24] Prognostic impact of comorbidity in elderly patients with head and neck squamous cell carcinoma (HNSCC)
    Moreno Jimenez, M. A.
    Gonzalez Cebrian, I.
    Collado Martin, R.
    Medina Magan, B.
    Ortega Granados, A. L.
    Mateos Salido, M. J.
    Alonso Calderon, R.
    Plata, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [25] RAPTOR protein overexpression is predictive of poor clinical outcomes in head and neck squamous cell carcinoma (HNSCC) patients
    Poon, Hui Yan
    Liu, Yuchen
    Su, Yu Xiong
    Chan, Jason Y. K.
    Lau, Chin Wang
    Lui, Vivian W. Y.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Novel Predictive Biomarkers in the Head and Neck Squamous Cell Carcinoma (HNSCC)
    Miniuk, Magdalena
    Reszec-Gielazyn, Joanna
    Bortnik, Piotr
    Borsukiewicz, Agata
    Mroczek, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [27] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    F Lemaire
    R Millon
    J Young
    A Cromer
    C Wasylyk
    I Schultz
    D Muller
    P Marchal
    C Zhao
    D Melle
    L Bracco
    J Abecassis
    B Wasylyk
    British Journal of Cancer, 2003, 89 : 1940 - 1949
  • [28] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Tumour stem cells in head and neck squamous cell carcinoma (HNSCC)
    Goldie, S. J.
    Watt, F. M.
    Price, R.
    ORAL ONCOLOGY, 2009, : 72 - 72
  • [30] PTEN and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC).
    Da Costa, Alexandre Andre B. A.
    Costa, Felipe D'Almeida
    De Oliveira, Andrea Cruz Ferraz
    Stecca, Carlos
    Oliveira, Audrey
    Alves, Ana Caroline Fonseca
    Camandaroba, Marcos Pedro Guedes
    Araujo, Daniel Vilarim
    Machado, Larissa
    De Lima, Vladmir Claudio Cordeiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345